CHDI
Meet Christina Sampaio, MD, PHD
CHDI Foundation, Inc. has appointed Cristina Sampaio, MD, PhD, as Chief Clinical Officer. In this newly-created position Sampaio will lead and develop CHDI’s clinical programs by building both internal capabilities and further developing collaborative relationships with external partners.
Cristina Sampaio, MD, PhD, Joins CHDI Foundation As Chief Clinical Officer
CHDI Foundation, Inc. has appointed Cristina Sampaio, MD, PhD to the newly-created position of Chief Clinical Officer.
Galenea and CHDI Foundation announce collaboration
Galenea Corp. and CHDI Foundation, Inc. have announced a collaboration to identify synaptic dysfunction linked to Huntington’s disease (HD) utilizing Galenea’s proprietary synaptic transmission drug discovery platform. Galenea’s innovative platform will provide new insights into the disease mechanism.
Events
HD Therapeutics Conference
Thoughtful presentations, high fives and overall a smart choice to attend.
World Congress on Huntington’s Disease
The Gordon Research Conference on CAG Triplet Repeat Disorders